europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

17/01/2023
PRESS RELEASE

Brussels, 17 January 2023 – An Industry Advisory Group (IAG) representing biotechnology across sectors, countries and through the innovation pathway has been launched to support EuropaBio’s new Biomanufacturing Platform.

The IAG includes SMEs, mid and large sized companies, plus National associations, with the aim to ensure that biomanufacturing is recognised and supported as a significant part of Europe’s economic growth in a rapidly accelerating global biomanufacturing market.

The 2023 IAG includes:

  • Ana Sofia Antunes, Mab Design (FR)
  • Audrey Bru, Lallemand (UK/FR)
  • Inga Matijosyte, LBTA (LT)
  • Matt Moran, IBEC (IRE)
  • Sarah Moundir, Novartis (CH)
  • Gwenaël Servant, Abolis (FR)
  • Sabrina Spina, Olon (IT)
  • Peter Steen Mortensen, Novozymes (DK)
  • Tineke Van hooland, Bio.be (BE)

The IAG kick starts the Biomanufacturing Platform growth in 2023, with the Biomanufacturing Policy Summit hosted on March 15 in Brussels. The Group will ensure industry-relevant definitions, vision, case studies and recommendations to policy stakeholders at national and European level so that Europe is globally competitive.

Biomanufacturing is already present within most sectors, whether product or process-based, including advanced therapies such as cell and gene therapy, food, materials and industry intermediates. It provides significant employment and economic growth, as Europe strives to meet the Green Deal and deliver advanced healthcare particularly in response to unmet needs such as those within rare diseases.

Dr Virginia Claudio, EuropaBio Senior Adviser and Programme Manager said “Biomanufacturing investments are of paramount importance for EU tech sovereignty and quality of life of EU citizens. The IAG behind the Biomanufacturing Platform brings the voices of industry and economic development for Europe and will ensure that it is always at the forefront of Europe’s policy priorities.”

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry


Read more
13/12/2022

SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies